p.109 抽出テキスト

Registry. Circ J 2017; 81: 1301-1306. PMID: 28450667 40. De Bruyne B, Fearon WF, Pijls NH, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 2014; 371: 1208-1217. PMID: 25176289 41. Fearon WF, Nishi T, De Bruyne B, et al. FAME 2 Trial Investigators. Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: Three-year follow-up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). Circulation 2018; 137: 480-487. PMID: 29097450 42. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010; 55: 2816-2821. PMID: 20579537 43. Nakamura M, Yamagishi M, Ueno T, et al. Modification of treatment strategy after FFR measurement: CVIT-DEFER registry. Cardiovasc Interv Ther 2015; 30: 12-21. PMID: 24816634 44. Van Belle E, Rioufol G, Pouillot C, et al. Investigators of the Registre Français de la FFR–R3F. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation 2014; 129: 173-185. PMID: 24255062 45. Nam CW, Mangiacapra F, Entjes R, et al. FAME Study Investigators. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011; 58: 1211-1218. PMID: 21903052 46. Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol 2012; 59: 1392-1402. PMID: 22154731 47. Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wavefree Ratio or Fractional Flow Reserve in PCI. N Engl J Med 2017; 376: 1824-1834. PMID: 28317458 48. Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. iFR-SWEDE- HEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med 2017; 376: 1813- 1823. PMID: 28317438 49. Svanerud J, Ahn JM, Jeremias A, et al. Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention 2018; 14: 806-814. PMID: 29790478 50. Van't Veer M, Pijls NHJ, Hennigan B, et al. Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal? J Am Coll Cardiol 2017; 70: 3088-3096. PMID: 29268922 51. Lee JM, Park J, Hwang D, et al. Similarity and Difference of Resting Distal to Aortic Coronary Pressure and Instantaneous Wave-Free Ratio. J Am Coll Cardiol 2017; 70: 2114-2123. PMID: 29050558 52. Meuwissen M, Chamuleau SA, Siebes M, et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 2001; 103: 184-187. PMID: 11208673 53. Lee JM, Choi KH, Hwang D, et al. Prognostic Implication of Thermodilution Coronary Flow Reserve in Patients Undergoing Fractional Flow Reserve Measurement. JACC Cardiovasc Interv 2018; 11: 1423-1433. PMID: 30093048 54. Allman KC. Noninvasive assessment myocardial viability: current status and future directions. J Nucl Cardiol 2013; 20: 618-637. PMID: 23771636 55. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001; 26: 147-186. PMID: 11276916 56. Sciagrà R, Bisi G, Santoro GM, et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997; 30: 384-391. PMID: 9247509 57. Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994; 89: 2552- 2561. PMID: 8205664 58. Patel P, Ivanov A, Ramasubbu K. Myocardial Viability and Revascularization: Current Understanding and Future Directions. Curr Atheroscler Rep 2016; 18: 32. PMID: 27115143 59. Matsunari I, Tamaki N, Ikeda M, et al. A Post-marketing Clinical Study to Confirm the Efficacy of 18F-fluorodeoxyglucose for the Diagnosis of Myocardial Viability: A Prospective Multicenter Study in Patients with Ischemic Heart Disease. Ann Nucl Cardiol 2016; 2: 9-20. 60. Ling LF, Marwick TH, Flores DR, et al. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging 2013; 6: 363-372. PMID: 23595888 61. Rischpler C, Langwieser N, Souvatzoglou M, et al. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake. Eur Heart J Cardiovasc Imaging 2015; 16: 661-669. PMID: 25680385 62. Shah DJ, Kim HW, James O, et al. Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA 2013; 309: 909-918. PMID: 23462787 63. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39: 1151-1158. PMID: 11923039 64. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2019; 40: 87-165. PMID: 30165437 65. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987; 113: 1006-1010. PMID: 3565227 66. Davis JW, Hartman CR, Lewis HD, et al. Cigarette smoking--induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 1985; 105: 479- 483. PMID: 3884719 67. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094-1100. PMID: 7648652 68. Taylor AE, Johnson DC, Kazemi H. Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation 1992; 86: 699-702. PMID: 1638735 69. Shimbo D, Child J, Davidson K, et al. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 2002; 89: 331-333. PMID: 11809437 70. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303-1309. PMID: 3683458 71. Pell JP, Haw S, Cobbe S, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 2008; 359: 482- 491. PMID: 18669427 72. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976; 2: 1525-1536. PMID: 1009386 73. Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2003: CD003041. PMID: 14583958 74. Gordon T, Kannel WB, McGee D, et al. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet 1974; 304: 1345-1348. PMID: 4143310 75. Fiore M, Bailey W, Cohen S, et al. Treating tobacco use and dependence. U.S. Department of Health and Human Services. 2000. 76. Gorin SS, Heck JE. Meta-analysis of the efficacy of tobacco counseling by health care providers. Cancer Epidemiol Biomarkers Prev 2004; 13: 2012-2022. PMID: 15598756 77. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007; 167: 1720-1728. PMID: 17846390 78. McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006; 296: 79- 86. PMID: 16820550 79. Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002; 10 Suppl: 97S-104S. PMID: 12490658 80. 日本肥満学会肥満症診療ガイドライン作成委員会.肥満症診療ガイドライン2016.ライフサイエンス出版 2016. 81. Sjöström L, Narbro K, Sjöström CD, et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752. PMID: 17715408 82. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014; 63: 2985-3023. PMID: 24239920 83. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation